Average Co-Inventor Count = 6.38
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Array Biopharma Inc. (25 from 329 patents)
2. Icos Corporation (11 from 164 patents)
3. Genentech, Inc. (8 from 3,221 patents)
4. Mirati Therapeutics, Inc. (6 from 38 patents)
5. Celgene Corporation (2 from 549 patents)
6. Genetech, Inc. (1 from 98 patents)
36 patents:
1. 11964989 - KRas G12D inhibitors
2. 11834453 - Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitors
3. 11780835 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
4. 11453683 - KRas G12D inhibitors
5. 11267812 - KRAS G12C inhibitors
6. 11247990 - Bicyclic fused pyridine compounds as inhibitors of TAM kinases
7. 11104676 - Pyrazolo[3,4-b]pyridine compounds as inhibitors of TAM and MET kinases
8. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
9. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
10. 10647715 - KRas G12C inhibitors
11. 10633381 - KRas G12C inhibitors
12. 10519126 - Serine/threonine kinase inhibitors
13. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
14. 10125134 - KRas G12C inhibitors
15. 9708290 - Serine/threonine kinase inhibitors